Evidence map›Paper›PMID 37458862›Full record

ReviewMedical oncology (Northwood, London, England)2023

Oncolytic viruses against cancer, promising or delusion?

Arash Letafati, Omid Salahi Ardekani, Mina Naderisemiromi, Mohammad Mehdi Fazeli, Nillofar Asadi Jemezghani, Jila Yavarian

Abstract readReview
PubMed Publisher
In one paragraph

Review in Medical oncology (Northwood, London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Arash LetafatiDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Omid Salahi ArdekaniResearch Center for Clinical Virology, Tehran University of Medical Science, Tehran, Iran.
Mina NaderisemiromiDepartment of Immunology, Faculty of Medicine and Health, The University of Manchester, Manchester, UK.
Mohammad Mehdi FazeliResearch Center for Clinical Virology, Tehran University of Medical Science, Tehran, Iran.
Nillofar Asadi JemezghaniMedical Doctor, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Jila YavarianDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. yavarian@tums.ac.ir.ORCID http://orcid.org/0000-0003-3239-9397

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer treatment is one of the most challenging topics in medical sciences. Different methods such as chemotherapy, tumor surgery, and immune checkpoint inhibitors therapy (ICIs) are potential approaches to treating cancer and killing tumor cells, but clinical studies have shown that they have been successful for a limited group of patients. Using viruses as a treatment can be considered as an effective treatment in the field of medicine. This is considered as a potential treatment, especially in comparison to chemotherapy, which has severe side effects related to the immune system. Most oncolytic viruses (OVs) have the potential to multiply in cancer cells, which are more than normal cells in malignant tissue and can induce immune responses. Therefore, tons of efforts and research have been started on the utilization of OVs as a treatment for cancer and have shown promising in treating cancers with less side effects. In this article, we have gathered studies about oncolytic viruses and their effectiveness in cancer treatment.Please confirm if the author names are presented accurately and in the correct sequence (given name, middle name/initial, family name). Author 1 Given name: [Omid Salahi] Last name [Ardekani], Author 2 Given name: [Mohammad Mehdi] Last name [Fazeli], Author 3 Given name: [Nillofar Asadi] Last name [Jemezghani]. Also, kindly confirm the details in the metadata are correct.Confirmed.

Indexed as

Drug-Related Side Effects and Adverse ReactionsNeoplasmsOncolytic VirotherapyOncolytic VirusesDelusionsHumansTreatment OutcomeCancerOncolytic virusesTherapyTreatmentTumor

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.